These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20306034)

  • 1. SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment.
    Pappatà S; Varrone A; Vicidomini C; Milan G; De Falco C; Sansone V; Iavarone A; Comerci M; Loré E; Panico MR; Quarantelli M; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1156-63. PubMed ID: 20306034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT.
    Varrone A; Soricelli A; Postiglione A; Salvatore M
    Clin Nucl Med; 1999 Sep; 24(9):660-5. PubMed ID: 10478740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
    Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain SPECT imaging using three different tracers in subacute cerebral infarction.
    Hashimoto J; Sasaki T; Itoh Y; Nakamura K; Kubo A; Amano T; Fukuuchi Y
    Clin Nucl Med; 1998 May; 23(5):275-7. PubMed ID: 9596150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment.
    Huang C; Wahlund LO; Svensson L; Winblad B; Julin P
    BMC Neurol; 2002 Sep; 2():9. PubMed ID: 12227833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study.
    Mathieu A; Vacca A; Serra A; Cauli A; Piga M; Porru G; Marrosu F; Sanna G; Piga M
    Lupus; 2010 Jul; 19(8):918-26. PubMed ID: 20427410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between Z-scores of VSRAD and regional cerebral blood flow of SPECT in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):284-92. PubMed ID: 20374539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.
    Ohyama M; Senda M; Ishiwata K; Kitamura S; Mishina M; Ishii K; Toyama H; Oda K; Katayama Y
    Ann Nucl Med; 1999 Oct; 13(5):309-15. PubMed ID: 10582800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.
    Caroli A; Testa C; Geroldi C; Nobili F; Barnden LR; Guerra UP; Bonetti M; Frisoni GB
    J Neurol; 2007 Dec; 254(12):1698-707. PubMed ID: 17990057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computed tomography perfusion differences in mild cognitive impairment.
    Johnson KA; Moran EK; Becker JA; Blacker D; Fischman AJ; Albert MS
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):240-7. PubMed ID: 17056633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F; Zauner H; Bergmann J; Kronbichler M; Spindler I; Golaszewski S; Trinka E; Staffen W
    Curr Alzheimer Res; 2019; 16(9):843-851. PubMed ID: 31453786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.